Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone

Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy

Paths to Innovation

As uncertainties cloud the future of funding support for higher education, UNLV’s ability to market its intellectual property becomes ever more crucial. Three projects provide textbook cases for how it’s done. Kwang Kim Mark Yoseloff Bryan Spangel

B→ρ,K⁎ transition form factors in AdS/QCD model

AbstractWe use the AdS/QCD distribution amplitudes for light mesons to calculate the transition form factors for B to ρ,K⁎ decays. These form factors are then utilized to make predictions for the semileptonic B→ρℓν and dileptonic B→K⁎μ+μ− decays. We compare our predictions to the experimental data from BaBar and LHCb

Expect the unexpected – implications for next phase of COVID-19 response

A case report of a 66 year old male patient with COVID 19 who presented late in the clinical course and subsequently developed respiratory failure requiring intubation, after initially experiencing diarrhoea.Publisher PDFPeer reviewe